IT201800001301A1 - Formulazioni in gel per la somministrazione orale di farmaci, in particolare nei pazienti disfagici - Google Patents

Formulazioni in gel per la somministrazione orale di farmaci, in particolare nei pazienti disfagici

Info

Publication number
IT201800001301A1
IT201800001301A1 IT201800001301A IT201800001301A IT201800001301A1 IT 201800001301 A1 IT201800001301 A1 IT 201800001301A1 IT 201800001301 A IT201800001301 A IT 201800001301A IT 201800001301 A IT201800001301 A IT 201800001301A IT 201800001301 A1 IT201800001301 A1 IT 201800001301A1
Authority
IT
Italy
Prior art keywords
drugs
oral administration
gel formulations
dysphagia patients
dysphagia
Prior art date
Application number
IT201800001301A
Other languages
English (en)
Inventor
Giulia Bonacucina
Marco Cespi
Luca Casettari
Elisabetta Torregiani
Serena Logrippo
Giovanni Filippo Palmieri
Diego Romano Perinelli
Roberta Ganzetti
Matteo Sestili
Original Assignee
Univ Degli Studi Di Camerino
Pharma & Food Consulting Srl
I N R C A Istituto Naz Riposo E Cura Anziani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Di Camerino, Pharma & Food Consulting Srl, I N R C A Istituto Naz Riposo E Cura Anziani filed Critical Univ Degli Studi Di Camerino
Priority to IT201800001301A priority Critical patent/IT201800001301A1/it
Priority to EP19151345.6A priority patent/EP3513782A1/en
Publication of IT201800001301A1 publication Critical patent/IT201800001301A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
IT201800001301A 2018-01-18 2018-01-18 Formulazioni in gel per la somministrazione orale di farmaci, in particolare nei pazienti disfagici IT201800001301A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT201800001301A IT201800001301A1 (it) 2018-01-18 2018-01-18 Formulazioni in gel per la somministrazione orale di farmaci, in particolare nei pazienti disfagici
EP19151345.6A EP3513782A1 (en) 2018-01-18 2019-01-11 Gel formulations for oral administration of drugs, in particular to dysphagic patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT201800001301A IT201800001301A1 (it) 2018-01-18 2018-01-18 Formulazioni in gel per la somministrazione orale di farmaci, in particolare nei pazienti disfagici

Publications (1)

Publication Number Publication Date
IT201800001301A1 true IT201800001301A1 (it) 2019-07-18

Family

ID=62089846

Family Applications (1)

Application Number Title Priority Date Filing Date
IT201800001301A IT201800001301A1 (it) 2018-01-18 2018-01-18 Formulazioni in gel per la somministrazione orale di farmaci, in particolare nei pazienti disfagici

Country Status (2)

Country Link
EP (1) EP3513782A1 (it)
IT (1) IT201800001301A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102381836B1 (ko) * 2019-10-22 2022-04-05 한국유나이티드제약 주식회사 콜린알포세레이트를 포함하는 소형 형태의 서방성 약학조성물
US11744866B2 (en) 2020-03-18 2023-09-05 Sabine Hazan Methods of preventing and treating COVID-19 infection with probiotics
US11253534B2 (en) 2020-03-23 2022-02-22 Sabine Hazan Method of preventing COVID-19 infection
US11278520B2 (en) 2020-03-31 2022-03-22 Sabine Hazan Method of preventing COVID-19 infection
IT202100020648A1 (it) * 2021-07-30 2023-01-30 Pharma & Food Consulting Srl Sistema di trasformazione di sodfs in forma gel

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277395B1 (en) * 1998-07-31 2001-08-21 Ryukakusan Co. Ltd. Swallowing-assistive drink
WO2001076634A1 (en) * 2000-04-05 2001-10-18 Richard Fuisz Oral delivery method and composition for solid medications or dietary supplements
WO2009098520A2 (en) * 2008-02-06 2009-08-13 University Of East Anglia Composition and method for assisting swallowing

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277395B1 (en) * 1998-07-31 2001-08-21 Ryukakusan Co. Ltd. Swallowing-assistive drink
WO2001076634A1 (en) * 2000-04-05 2001-10-18 Richard Fuisz Oral delivery method and composition for solid medications or dietary supplements
WO2009098520A2 (en) * 2008-02-06 2009-08-13 University Of East Anglia Composition and method for assisting swallowing

Also Published As

Publication number Publication date
EP3513782A1 (en) 2019-07-24

Similar Documents

Publication Publication Date Title
IT201800001301A1 (it) Formulazioni in gel per la somministrazione orale di farmaci, in particolare nei pazienti disfagici
CY1122786T1 (el) Δοσολογικα σχηματα για ενωσεις κατηγοριας εχινοκανδινης
MA52257A (fr) Compositions pharmaceutiques comprenant blautia et leur administration orale
MY187047A (en) Selective pyy compounds and uses thereof
HK1247822A1 (zh) 用於活性劑口服給藥的製劑
DK3727555T3 (da) Oral delivery of active drug substances
CY1118057T1 (el) Φαρμακευτικη συνθεση για στοματικη χορηγηση
EA201792592A1 (ru) Фармацевтические препараты, содержащие тенофовир и эмтрицитабин
CO2019000643A2 (es) Formulaciones gastrorretentivas orales y usos de las mismas
EA201792591A1 (ru) Фармацевтические препараты
DK3709978T3 (da) Farmaceutisk oral formulering omfattende bakterier
MX2018012618A (es) Composiciones farmaceuticas orales de mesalazina.
IL264880A (en) Preparations for oral administration of active substances
CY1119532T1 (el) (s)-πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη
CY1122882T1 (el) Παραγωγα 3-(καρβοξυαιθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου
DK3866767T3 (da) Farmaceutisk sammensætning til oral indgivelse omfattende aminopyrimidinderivat eller salt deraf
MA55015A (fr) Formulations pharmaceutiques
CY1121921T1 (el) Φαρμακευτικα σκευασματα
MA41326A (fr) Formulations pharmaceutiques comprenant du cangrelor de haute pureté et leurs procédés de préparation et d'utilisation
CY1124092T1 (el) Φυσικως και χημικως σταθερα απο του στοματος γιβινοστατης
AR108233A1 (es) Composiciones farmacéuticas orales de nicotinamida
EA201991287A1 (ru) Твердые фармацевтические композиции на основе тикагрелора для перорального применения
ES2850277R1 (es) Composiciones de administración farmacéutica y usos de las mismas
SG11202101547WA (en) Pharmaceutical composition for oral administration
CY1120749T1 (el) Φαρμακευτικες δοσολογικες μορφες